Kvindelige patienter bør derfor undgå at blive gravide under behandlingen og indtil seks måneder efter behandlingen, og det tilrådes mandlige patienter at undgå at avle børn under behandlingen og indtil seks måneder efter behandlingen med Busilvex.
Because of this, female patients should not become pregnant during treatment and for up to six months afterwards, and male patients are advised not to father a child during and for up to six months after treatment with Busilvex.